Novo Integrated Sciences Corp (NVOS): Rega marang dodolan
How can medical sustainability be improved through data digitalization? P/S multiple fluctuations on this GURU.Markets chart for Novo Integrated Sciences (NVOS) show that the parameter reaches 0.20. However, the trend is complicated by a working capital deficit and risky acquisitions. The situation is further exacerbated by a lack of operating profit and the marginalization of the business against tech giants, which calls into question the effectiveness of current investment attraction methods.
Novo Integrated (NVOS) - rincian metrik lan laporan keuangan
- rega saiki lan proyeksi nilai saham:
- data kapitalisasi bursa:
- data nilai buku modal saham:
- rincian struktur utang lan likuiditas bisnis:
Rasio Utang marang Ekuitas Novo Integrated Sciences|NVOS - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka cendhak marang modal Novo Integrated Sciences|NVOS - Gunggung utang perusahaan|Utang-utang marang nilai buku Novo Integrated Sciences Corp|NVOS - Utang jangka dawa perusahaan|Tanggungan jangka cendhak Novo Integrated Sciences|Rasio jangkoan perantara novointegrated.com
- informasi bathi lan kelipatan valuasi:
NVOS - Bathi resik|Proyeksi bathi mangsa ngarep Novo Integrated Sciences|NVOS - Koefisien rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep Novo Integrated|NVOS - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Novo Integrated Sciences Corp|NVOS - Bathi operasional EBITDA|Bathi saben saham sajrone 12 wulan pungkasan Novo Integrated Sciences|NVOS - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan novointegrated.com|NVOS - Wutah bathi saben saham ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Novo Integrated Sciences
- rincian pendapatan lan dodolan emiten:
Analisis umum perusahaan:NVOS - Novo Integrated Sciences, Inc.
The complexity of integrating medical and IT services at Novo Integrated Sciences (NVOS) amid a capital shortage increases risks during aggressive expansion. The ratio of market capitalization to annual revenue allows for an assessment of the premium paid for this growth; therefore, analyzing P/S levels on this chart helps investors timely recognize signs of an overbought asset or a signal of business stagnation.
Perusahaan pesaing
HCA (HCA Healthcare) - Rasio kapitalisasi pasar marang pendapatan|Tenet Healthcare Corporation - Kapitalisasi marang pendapatan|Fresenius Medical (FMS) - Rega marang dodolan|Solventum Corp - Multiplikator P/S|Rasio rega marang dodolan EHC|Universal Health Services (UHS) - Rasio rega marang pendapatan|DaVita - Rasio kapitalisasi pasar marang pendapatan|Kapitalisasi marang pendapatan RDNT|OPCH: Rasio kapitalisasi pasar marang pendapatan|Kapitalisasi marang pendapatan SGRY (Surgery Partners, Inc.)|PINC (Premier, Inc.) - Rasio kapitalisasi pasar marang pendapatan|National Vision - Kapitalisasi marang pendapatan|Koefisien rega marang pendapatan Progyny Inc (PGNY)|Ardent Health - Multiplikator P/S|Koefisien rega marang pendapatan Select Medical Corp SEM|ASTH: Multiplikator P/S|Rasio kapitalisasi marang pendapatan MD|USPH (US Physical Therapy Inc) - Multiplikator P/S|PNTG: Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Organogenesis Corp (ORGO)|NUTX (Nutex Health Corp) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S AUNA (Auna S.A.)|SBC Medical Group Holdings Inc (SBC) - Rega marang dodolan|EOLS - Rasio rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan CYH (Community Health Systems Inc)|SKIN (beautyhealth.com) - Kapitalisasi marang pendapatan|Rasio kapitalisasi marang pendapatan MDWD|Rasio rega marang pendapatan biote Corp.|Rega marang dodolan thejoint.com JYNT|Multiplikator P/S DCGO|Kapitalisasi marang pendapatan P3 Health PIII|Multiplikator P/S GANX (Gain Therapeutics Inc.)|Multiplikator P/S EUDA Health Holdings Limited EUDA|baselmedical.com - Multiplikator P/S|CLGN: Rasio rega marang pendapatan|Cuprina Holdings (Cayman) Ltd. (CUPR) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan Concord Medical|AMS (American Shared Hospital Services Inc) - Multiplikator P/S|MEDIROM Corp (MRM) - Koefisien rega marang pendapatan|Multiplikator P/S ALBT|Koefisien rega marang pendapatan DIH Holding|Multiplikator P/S XAGE (carmellcosmetics.com)|NIVF: Rasio kapitalisasi marang pendapatan|ATIP: Kapitalisasi marang pendapatan|CareMax Medical Group - Kapitalisasi marang volume dodolan|Kindly MD (KDLY) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan MODV|SSY (SunLink Health Systems Inc.) - Multiplikator P/S|BACK (IMAC Holdings Inc) - Kapitalisasi marang volume dodolan
